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Abstract While several models have proven to result in
accurate estimations when measuring cardiac output using
indicator dilution, the mono-exponential model has pri-
marily been chosen for deriving coronary blood/plasma
volume. In this study, we compared four models to derive
coronary plasma volume using indicator dilution; the
mono-exponential, power-law, gamma-variate, and local
density random walk (LDRW) model. In anesthetized goats
(N = 14), we determined the distribution volume of high
molecular weight (2,000 kDa) dextrans. A bolus injection
(1.0 ml, 0.65 mg/ml) was given intracoronary and coro-
nary venous blood samples were taken every 0.5–1.0 s;
outﬂow curves were analyzed using the four aforemen-
tioned models. Measurements were done at baseline and
during adenosine infusion. Absolute coronary plasma vol-
ume estimates varied by *25% between models, while the
relative volume increase during adenosine infusion was
similar for all models. The gamma-variate, LDRW, and
mono-exponential model resulted in volumes correspond-
ing with literature, whereas the power-model seemed to
overestimate the coronary plasma volume. The gamma-
variate and LDRW model appear to be suitable alternative
models to the mono-exponential model to analyze coronary
indicator-dilution curves, particularly since these models
are minimally inﬂuenced by outliers and do not depend on
data of the descending slope of the curve only.
Keywords Coronary indicator-dilution technique  
Mono-exponential model   Power-law model  
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1 Introduction
The indicator-dilution technique was ﬁrst used for the mea-
surement of cardiac output. Later, this technique was
extended to measurements of regional blood ﬂow and to
measure the blood volume in the circulation of the heart and
lungs [22, 35]. Recently, we applied the indicator-dilution
technique to determine the contribution of the endothelial
glycocalyx to adenosine-induced changes in coronary blood
volume. Coronary blood volume at baseline and during
coronary administration of adenosine was compared, before
and after hyaluronidase treatment of the glycocalyx [5]. We
observed that, in contrast to control conditions during which
adenosine-induced increases in coronary blood volume and
ﬂow appeared to be nicely matched, enzymatic degradation
of the glycocalyx was associated with an impaired increase
in volume yet unaltered ﬂow response during adenosine
infusion compared to corresponding baseline [5]. Because a
mismatchintheincreaseinbloodvolumeversustheincrease
inﬂowduringexercisemaybeexpectedtobeassociatedwith
an impaired coupling of nutrient exchange in the capillaries
to nutrient delivery by blood ﬂow, it might be of clinical
relevance to measure coronary blood volume (reserve) in
addition to coronary blood ﬂow (reserve) in patients that are
at risk for development of glycocalyx damage.
In these previous experiments, ﬂuorescently labeled
2,000-kDa dextrans (as plasma tracer) and labeled red blood
cellswereinjectedintheleftmaincoronaryarteryandblood
was collected from the great cardiac vein; tracer outﬂow
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transit time (MTT) of both tracers, and, together with the
measured coronary blood ﬂow, ultimately coronary blood
volume.Bloodsamplesweretakenevery0.5 s,resultingina
limited amount of data on the descending part of the curve
before the onset of recirculation. Because of this, the indi-
cator-dilution curves were analyzed using a local density
random walk (LDRW) model, rather than the commonly
used mono-exponential model, since it requires less data of
the descending slope of the curve. Using the LDRW model,
coronarybloodvolumesof18.9 ± 1.1 ml/100 ghearttissue
were derived at baseline, while the volumes during adeno-
sine infusion were increased to 33.2 ± 5.3 ml/100 g. After
hyaluronidase, the volume was 26.3 ± 2.7 ml/100 g in
control and33.9 ± 6.8 ml/100 gduringadenosineinfusion,
indicating an impaired ability for adenosine to recruit blood
volume. In this study, we wanted to know how the used
model contributed to the calculated volumes.
Although, the LDRW ﬁt has been recognized in the past
fortheﬁtofindicator-dilutioncurves,e.g.,fordetermination
ofcardiacoutput[26],thismodelhasnotbeenusedfortheﬁt
of coronary indicator-dilution curves so far. With respect to
the coronary circulation, the mono-exponential ﬁt has typi-
cally been used, and the following volumes have been
reported: 9.4–14.8 ml/100 g tissue at perfusion ﬂows of
40–220 ml/min/100 g in the study of Ziegler and Goresky
[33]and15.6 ml/100 ginthestudiesofHirscheandLochner
[11] as well as Morgenstern et al. [27]. The gamma-variate
and LDRW ﬁts, could, however, be more suitable for coro-
nary volume estimations since the parameters of these
models are based on the ascending and descending slope of
the data curve, while the mono-exponential model is solely
based on a selection of the descendingslope.Thepower-law
[1], also based only on part of the descending slope, has in
one previous study been applied to measurements of water
washout in isolated hearts. Although, the results were very
promising, the model has never been applied to an intra-
vasculartracerinaninsitusetup.Inthisstudy,we,therefore,
decided to compare a selection of these 4 indicator-dilution
models to our experimental data, to determine what the
inﬂuence of the model used is on the outcome of our coro-
nary blood volume estimations and which of these four
modelsisbestsuitable(basedonpracticabilityandsignal-to-
noise ratio) to ﬁt tracer outﬂow curves when measuring
coronary volumes using the indicator-dilution technique.
2 Methods
2.1 General surgery and anesthesia
All procedures and protocols were approved by the animal
care and use committee of Maastricht University. The
investigations described were conformed with the Guide
for the Care and Use of Laboratory Animals. The data
being analyzed in this study was from experiments on adult
female goats of 18–28 kg (N = 14) in which adenosine-
induced increases in coronary blood volume were mea-
sured. They included N = 6 experiments presented and
described in our previous study [5]. In short, after a left
thoracotomy, the great cardiac vein was cannulated via the
azygos vein to obtain coronary venous blood samples.
Subsequently, the left carotid artery was cannulated and a
stainless steel Gregg cannula was inserted in the aorta via a
purse string. The Gregg cannula was ligated into the left
main coronary artery, without disrupting the coronary ﬂow.
Coronary perfusion was controlled using a roller pump
perfusion system (total volume 110 ml) [30], see Fig. 1.
The perfusion pressure (Pperf) was measured at the tip of
the Gregg cannula. An inline ﬂow probe (6 mm Transonic
ﬂowprobe, Transonic Systems Inc.) was interpositioned
into the perfusion line of the perfusion system to measure
coronary blood ﬂow (Qperf). The femoral blood pressure
(Pfem), left ventricle pressure (Plv), Pperf, Qperf, and heart
rate (HR, determined from Plv) were stored on a personal
computer for off-line analysis (IDEEQ 250 Hz, IDEE). At
the end of the experimental procedures a battery was
placed on the heart to induce ventricular ﬁbrillation. At the
end of the experiment, the left main coronary artery was
injected with a mixture of gelatin and white paint (latex) at
37C. After cooling, the colored tissue could be dissected
and weighed.
2.2 Experimental protocol
After surgery, the preparation was allowed to equilibrate
for 30 min. In each animal, the distribution volume of the
plasma tracer FITC-labeled dextrans with a molecular
weight (MW) of 2,000 kDa (Dex-2000, Sigma-Aldrich,
0.65 mg/ml) was measured using the indicator-dilution
technique. A bolus injection of tracer (1.0 ml) was given
by hand into the left main via the perfusion pressure
catheter at the tip of the Gregg cannula. The catheter in the
great cardiac vein was connected to a roller pump enabling
coronary venous blood to be collected at a rate of 24.2 ml/
min (205S Watson Marlow), the total volume of the sam-
pling system was 4 ml. Blood was sampled in consecutive
1.5 ml tubes at intervals of 0.5–1 s for 50 s; the ﬁrst 10 and
last 20 samples were taken at an interval of 1 s, while the
40 samples in between, where the major part of the indi-
cator-dilution curve is expected, were taken every half a
second. Therefore, a total of 70 samples per volume mea-
surement were obtained after the tracer injection. Blood
was subsequently centrifuged, and plasma Dex-2000 con-
centration was analyzed using ﬂuorometry (Victor3; Perkin
Elmer). In 12 experiments, the measurement was repeated
1472 Med Biol Eng Comput (2011) 49:1471–1479
123during intracoronary adenosine infusion (0.47 ± 0.03 mg/
kg/h), to detect imposed changes in coronary plasma vol-
ume by this vasodilator.
2.3 Data analysis
Analysis of the samples resulted in 70 coronary venous
plasma dextran concentrations over time per coronary
volume measurement. All measured data were corrected
for the background value (average value of the ﬁrst three
samples) and the transfer function, h(t), was obtained by
dividing the measured concentration (mg/ml) times the
carrier (plasma) ﬂow (ml/s) by the amount that was
injected (mg). Plasma ﬂow was determined from coronary
blood ﬂow and hematocrit. The Dex-2000 transfer curves
were ﬁtted with four different models using Matlab
 (the
MathWorks, Inc., Natick, MA).
2.4 Models based on the descending slope
The mono-exponential [9, 10] and power-law model [1] are
solely based on information obtained from a selection of
the descending part of the transfer curve. The mono-
exponential function assumes an exponential outﬂow of the
tracer and the power-law function assumes that the outﬂow
can be approached as being a fractal process. For the
mono-exponential model, the logarithm of the transfer
function was taken, while for the power-law model, both
the logarithm of the transfer function and time were
required. To obtain the model parameters, a straight line,
using robust linear regression, was drawn through the data
from one point above 70% up to 30% [12] of the peak
height on the descending slope of the transfer function
(Fig. 2a–d). Subsequently, for the mono-exponential
model, the curve was ﬁtted, from one point above 70% of
the peak height forward, according to Eq. 1.
hðtÞexp ¼ eaebt ¼ Aebt: ð1Þ
The transfer function according the power-law was ﬁtted
using Eq. 2.
hðtÞPL ¼ Bat a 1: ð2Þ
2.5 Models based on both ascending and descending
slope
The gamma-variate model [21, 26] and LDRW model [3,
26] take, in addition to the descending part, the ascending
part and peak of the curve into account as well. Fitting the
transfer function by the gamma-variate model was done by
using Eq. 3.
hðtÞc ¼ hmaxðtmax   t0Þ
 bebðt   t0Þ
be
 bðt t0Þ
ðtmax t0Þ: ð3Þ
The parameters (hmax, the maximal value of h(t), tmax,
the time at which h(t) is at maximum, t0, the delay time
from t = 0 to the time the function begins, and b, a free
parameter) in Eq. 3 are independent of each other [21]
meaning that one parameter can change without having an
inﬂuence on any of the other parameters. The LDRW
model is described by Eq. 4,
hðtÞLDRW ¼
m
lh
ek
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
kl
2pðt   t0Þ
s
e
 k
2
ðt t0Þ
l þ
l
ðt t0Þ
  
: ð4Þ
and the parameters are deﬁned as, m is the mass of the
injected tracer, l is the transit time of the median indicator
particle, h is the ﬂow of the carrier, k being a dimensionless
parameter equal to the ratio between convection and dif-
fusion in the dilution system (related to the skewness or
asymmetry of the curve), and t0 represents the zero time of
the distribution [25, 26].
To prevent that the ﬁtting based on these models con-
verges into local minima, we used multiple linear regres-
sion as described by Mischi et al. [25]. Data between 5% of
the peak height on the ascending slope up to 30% of the
maximum peak value on the descending slope of the
transfer function curve were compared with the data
obtained from the model [24, 26], Fig. 2e–h. To determine
how well the ﬁt of the gamma-variate and LDRW models
corresponded with the transfer function, the determination
coefﬁcient (R
2) was calculated over the selection used to
determine the model parameters.
Fig. 1 Arterial coronary perfusion system. Blood collected from the
left carotid artery was heated and ﬁltered, and circulated with a roller
pump via a reservoir into the left main coronary artery. Blood level
and pressure in the reservoir were kept constant. Perfusion pressure
(Pperf) was measured at the tip of the Gregg cannula. An inline ﬂow
probe was interpositioned into the perfusion system to measure
coronary blood ﬂow (Qperf)
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123The quality of the ﬁt in correspondence with the transfer
function was evaluated by measuring the difference
between ﬁt and data for that part of the curve that was ﬁtted
by all four models. To do so, the area under the curve from
one point above 70% of the peak height on the descending
slope forward was calculated and expressed as percentage
of the area under the curve of the coronary transfer function
Areafit
Areatransfer   100%
  
:
2.6 Calculation of coronary plasma volume
Using the data from the ﬁtted curve the MTT was calcu-
lated according to Eq. 5 [22, 25], in which C(t) is the ﬁtted
Dex-2000 outﬂow concentration.
MTT ¼
R
tCðtÞdt R
CðtÞdt
: ð5Þ
The MTT of the tracer was corrected for the volume of
the sampling catheter by subtraction of the sampling transit
time (9.9 s), i.e., dividing the sampling catheter volume
(4 ml) by the sampling ﬂow (24.2 ml/min). Multiplying the
corrected MTT with the tracer carrier ﬂow (plasma ﬂow)
gave the distribution volume of the tracer [22].
2.7 Statistics
Differences in MTT, volume, area under the curve and, for
the gamma-variate and LDRW model, the determination
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Fig. 2 Two examples (left and
right) of a transfer function
ﬁtted with the four different
models a, b mono-exponential,
c, d power-law, e, f gamma-
variate, and g, h LDRW model.
The measured data is indicated
by the open circle and gray line,
the black lines are ﬁtted curves
based on the data one point
above 70 up to 30% of the
height of the peak on the
descending slope of the transfer
function (a–d) and all data up to
30% of the peak height on the
descending slope of the transfer
function (e–h). The data used by
the models are marked by
closed squares. Data not yet
corrected for the transit time of
the sampling catheter (9.9 s)
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123coefﬁcient were tested between the four models using a
t test, for both conditions (i.e., baseline and adenosine). In
addition, differences between data obtained at baseline and
during adenosine infusion were tested using a t test as well.
Results were considered statistically signiﬁcant with
P\0.05. Summary data are reported as mean ± SEM.
3 Results
Hemodynamic parameters of the measurements are pre-
sented in Tables 1 and 2. During the infusion of adenosine
in the left main coronary artery Qperf was signiﬁcantly
increased, in spite of the fact that the perfusion pressure was
reduced (P\0.05). The prevailing ﬂows differed sub-
stantially between experiments (range 63.5–424.6 ml/min/
100 g at baseline and 236.0–539.5 ml/min/100 g during
adenosine infusion). These ﬂows were associated with an
estimated time of onset of recirculation, determined from
the volume of the perfusion system (110 ml) divided by the
coronary ﬂow, of 42.6 ± 5.5 s, with a range of 20.7–95.5 s,
at baseline and 22.7 ± 1.9 s (range 13.3–33.4 s) during
adenosine infusion.
Figure 2 shows two examples of transfer functions
obtained during baseline conditions, and the way they are
ﬁtted by the four models, i.e., the mono-exponential (a, b),
power-law (c, d), gamma-variate (e–f), and LDRW (g, h)
model. Two differences are evident when comparing the
results of the mono-exponential and power-law model
versus the results of the gamma-variate and LDRW model.
First, the difference in descending slopes of the curves. The
gamma-variate and LDRW model derived ﬁts appear to
have a steeper descending slope than their transfer func-
tions (see Fig. 2e–h), while this difference was less for the
models solely based on the descending slope. Nevertheless,
the tail of all four models is below the actual measured
data, as represented by the area under curve of the ﬁtted
data as percentage of area under coronary transfer curve in
Fig. 3. Second, the ﬁts by the mono-exponential and
power-law model were found to contain more irregularities
since they did not ﬁt the entire (ascending and descending)
curve (Fig. 2b, d).
For one experiment during adenosine infusion there were
notenoughdatapointsontheselectedpartofthedescending
slope of the transfer function to perform robust regression.
This experiment was, therefore, not included in the further
comparisons of MTT and volume between the models. The
derived MTTs of the experiments are given in Fig. 4.
Compared to baseline, there was no change in MTT of all
four models during adenosine infusion. The paired volume
estimates (MTT times the coronary plasma ﬂow) are shown
in Fig. 5. In line with the higher MTTs, the coronary plasma
volume per 100 g heart tissue at baseline and during aden-
osine infusion determined using the power-law model were
signiﬁcantly larger than the volumes estimated using the
other three models, while the mono-exponential model-
derived coronary plasma volume was signiﬁcant larger than
Table 1 Hemodynamic parameters (mean ± SE)
Baseline (N = 14) Adenosine (N = 12)
Plv (mmHg) 114.8 ± 11.4 114.5 ± 11.2
Pfem (mmHg) 94.7 ± 12.5 87.7 ± 11.8
Qperf (ml/min/100g) 225.7 ± 25.5 388.4 ± 27.2*
Pperf (mmHg) 128.0 ± 4.0 93.6 ± 4.7*
HR (BPM) 132.1 ± 7.5 129.7 ± 8.7
Htc (venous) (%) 23.3 ± 2.1 22.5 ± 1.9
Values are mean ± SE
* Signiﬁcant from baseline measurement (P\0.05)
Table 2 Accuracy of the ﬁts (mean ± SE)
Model Determination coefﬁcient
Baseline Adenosine
Gamma-variate 0.97 ± 0.01 0.94 ± 0.02
LDRW 0.97 ± 0.01 0.94 ± 0.02
Values are mean ± SE
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Fig. 3 The area under the curve from one point above 70% of the
peak height on the descending slope forward normalized to the area
under the curve of the measured data at baseline (a) and during
adenosine infusion (b). *P\0.05 compared to all other models,
P\0.05 compared to the power-law and gamma-variate model,
P\0.05 compared to the power-law and gamma-variate model
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123those from the gamma-variate and at baseline from the
LDRW model. During adenosine infusion, the estimated
coronary plasma volume was equally increased (P\0.05)
for the mono-exponential, gamma-variate, and LDRW
model,a1.6 timesincreaseinvolumewasmeasured.Forthe
power-law model, there was a trend toward an increase in
coronary plasma volume during adenosine infusion com-
pared to baseline (P = 0.055).
4 Discussion
In this study, four indicator-dilution models were compared
for determination of coronary plasma volumes in the in situ
goat heart. Signiﬁcant differences in obtained MTTs and
volumes were found between the models, illustrating the
contribution of the used model in determination of coro-
nary volume when using tracer dilution. However, when
interested in relative changes during vasodilator infusion,
the mono-exponential, gamma-variate, and LDRW model
were equally suitable to detect a change in coronary plasma
volume (baseline compared to adenosine, P\0.05). The
relative increase in coronary plasma volume found using
the power-law model was less conclusive (P = 0.055). Our
data suggest that, in addition to the contemporary mono-
exponential model, alternative models, such as the gamma-
variate and LDRW model, are well suited for the analyses
of coronary indicator-dilution models, particularly in con-
ditions of a limited sampling rate.
4.1 Indicator-dilution technique
The theory and requirements of the indicator-dilution
technique have been reviewed by Meier et al. [22] and
Zierler [35]. Indicator dilution is based on the principle that
the ﬂow through a system or the volume of that system can
be measured by injection of a known quantity of an indi-
cator into the system and measuring its concentration over
time at a speciﬁc point in the system (i.e., the indicator-
dilution curve). Using the indicator-dilution curve, the
MTT, denoting the average time it takes for the indicator to
travel from the point of injection to the point of sampling,
can be derived. Multiplying the MTT with the indicator
ﬂow through the system, results in the distribution volume
of the indicator. One important assumption, no recircula-
tion, is normally violated in in vivo measurements. In this
in situ study, we used a perfusion system with a relative
large volume that delayed recirculation. The estimated
moment of recirculation ranged from a minimum of 13.3 to
a maximum of 95.5 s. The time it takes for the blood to
circulate from the great cardiac vein (outﬂow of the heart)
to the carotid artery (entrance of the perfusion system) was
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Fig. 4 The derived MTT (N = 11) for all four models at baseline
(a) and during adenosine infusion (b). *P\0.05 compared to mono-
exponential, gamma-variate, and LDRW model,
#P\0.05 compared
to power-law, gamma-variate, and LDRW model,
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Fig. 5 The derived coronary plasma volumes per 100 g heart tissue
(N = 11) for all four models at baseline (a) and during adenosine
infusion (b). *P\0.05 compared to mono-exponential, gamma-
variate, and LDRW model,
#P\0.05 compared to power-law,
gamma-variate, and LDRW model,
P\0.05 compared to power-
law and gamma-variate model,
P\0.05 compared to corresponding
baseline measurement
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123not taken into account in these numbers. Recirculation
(based on the perfusion ﬂow and volume of the perfusion
system: 42.6 ± 5.5 s at baseline and 22.7 ± 1.9 s during
adenosine infusion) appeared in this study at least 5 s after
the last sample that was selected for the determination of
the model parameters (7.8 ± 0.5 and 7.1 ± 0.4 s at base-
line and during adenosine infusion, respectively). There-
fore, a contribution of recirculation to the ﬁts can be
neglected in this study.
4.2 Tail of the curve
All four models tested provided a ﬁt through the data in
which the tail of the curve was below the measured data.
The power-law model provided ﬁts corresponding best
with the measured data (see Fig. 3) while the ﬁts of the
LDRW and in particular the gamma-variate model dif-
fered signiﬁcantly more from the measured data (area of
the ﬁt was 37.4 ± 6.2 and 32.3 ± 5.2% of the area under
the curve for the LDRW and gamma-variate model,
respectively). As discussed in the previous paragraph, the
difference between ﬁt and data cannot be explained by
recirculation of the tracer. A possible cause for the dif-
ference is the organ of interest, the coronary vasculature.
Bassingthwaighte and coworkers [20] have studied indi-
cator-dilution curves in single vessels, as well as in the
coronary, renal, and pulmonary circulation. They sug-
gested that the late, slowly decreasing tails observed when
studying the coronary circulation, causing a difference
between model and measured data, could only be
explained by the coronary bed itself [20]. For example,
local arterial reversed ﬂow with pulsatile intramyocardial
tension development could cause changes in the tail of
transfer curves that cannot be described accurately by any
of the models. Mischi et al. [26] found in an in vitro setup
and in patients (left and right ventricle) using the LDRW
ﬁt a much better agreement between the measured and
estimated data, including the lower part of the curves,
supporting the idea that the coronary bed, instead of the
choice of model, may be an important contributor to the
difference between model and measured data in this and
previous studies. Therefore, it must be noted that a better
ﬁt of the tail of coronary indicator-dilution curves might
not necessarily result in more accurate volume
estimations.
Nevertheless, a steeper descending slope for the LDRW
and gamma-variate model compared to measured data,
although less than in the coronary vasculature, was also
observed by Millard [24] and Thompson et al. [31], while
Mischi et al. [26] showed that the estimated volume by
these models provided underestimations for larger volumes
(3.4 and 7.4% at a volume of 1,080 ml, for the gamma-
variate and LDRW model, respectively), in their in vitro
and in vivo measurements for cardiac output.
4.3 Ascending slope
The gamma-variate and LDRW model ﬁt and explain not
only the descending part of the transfer curve but the
ascending part of the curve, the peak, and the start of the
descending slope of the transfer curve as well. As a result,
these ﬁts are less sensitive to noise and irregularities.
Bogaard et al. [4] found in their study that the results of the
mono-exponential method were seriously affected by noise
in the data, introducing a systematic error (overestimation
of MTT) which considerably reduced the accuracy of this
model. On the contrary, noise in the data did not have a
signiﬁcant effect on the outcome of the LDRW model in
their study. In addition, the number of data points used for
the ﬁt is much larger for the gamma-variate and LDRW
model compared to the mono-exponential and power-law
model. Although, already one point above 70% of peak
height was included to determine the model parameters,
one of the experiments still lacked sufﬁcient data to per-
form robust linear regression. Selection of less data, inev-
itable when no or a low volume perfusion system is used,
seems, therefore, not an option for the mono-exponential
and power-law model. In contrast, the gamma-variate and
LDRW model require only few data points of the
descending slope since these models take the ascending
slope into consideration as well.
4.4 Coronary plasma volume
Certainly, based on our data it cannot be determined which
model provides the most accurate volume estimations,
particularly because a reliable in vitro setup of the coronary
vasculature is not available for testing. A large range of
coronary vascular volumes has been reported in the liter-
ature (4 up to 17.8 ml/100 g [11, 18, 27, 33]). The differ-
ences in reported values can be explained by the fact that
either plasma or blood volume were measured, by differ-
ences in experimental conditions (in vivo [6, 11, 27, 33],
beating isolated hearts [29] or arrested isolated hearts [16–
18]) and the techniques used (histological measurements
[8], the use of a silicone cast [16–18], and the dilution of
speciﬁc blood or plasma indicators [6, 11, 27, 33]). Our
reported coronary baseline blood volume of 14–19 ml/
100 g is in the range of coronary plasma volumes (from 11
up to 17.8 ml/100 g) [11, 27, 33] found in literature using
indicator dilution. The measured volumes depend on per-
fusion pressure and coronary blood ﬂow [27]. In this study,
we measured a baseline blood ﬂow of 225.7 ± 25.5 ml/
min/100 g. Whereas baseline coronary blood ﬂows repor-
ted in anesthetized large animals in the literature are
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study seem explained by a reduction in basal vasomotor
tone of the resistance vessels due to the instrumentation of
the heart, including the use of a perfusion system, and the
relatively high HRs and perfusion pressures. The calculated
MTTs, independent of the ﬂow, are signiﬁcantly lower than
the MTT per 100 g heart tissue found by Ziegler and
Goresky [33] in the dog heart, except for the power-law
model. In their study, these investigators found a MTT of
7.3 ± 0.4 s using exponential extrapolation of the data. In
this study, we determined MTTs of 5.6 ± 0.5, 6.9 ± 0.7,
5.0 ± 0.4, and 5.1 ± 0.4 s for the mono-exponential,
power-law, gamma-variate, and LDRW model, respec-
tively. The differences in MTT might be explained by
species and experimental differences, such as a different
anesthesia and perfusion system, as well as a different
tracer used to determine coronary plasma volume. In this
study, dextrans with a MW of 2,000 kDa were used while
Ziegler and Goresky [33] used albumin, a tracer which has
been suggested to not only distribute in the plasma but to
access a part of the endothelial glycocalyx as well [32]. It
cannot be ruled out that the additional distribution in the
glycocalyx compartment might have resulted in a pro-
longed MTT and coronary plasma volume [32].
As far as we know, in the literature, there have been no
reports of indicator dilution-based coronary volumes dur-
ing maximal vasodilation using adenosine. We found that
the relative increase in coronary plasma volume during
adenosine infusion compared to baseline volume was not
different for the mono-exponential, gamma-variate, and
LDRW model, i.e., appeared to be model independent. A
similar trend was observed for the power-law model. The
1.6 times increase in coronary plasma volume measured
during adenosine infusion corresponds well with reported
coronary volume increases during adenosine infusion-
induced vasodilation measured using X-ray contrast
enhancement (1.68-fold increase) [13] and myocardial
radioactivity (1.75-fold increase) [6].
While this data show that increases in coronary plasma
volume and ﬂow occur concomitantly in response to
adenosine infusion, we found in our previous study that
these increases in coronary blood volume versus ﬂow
become uncoupled after enzymatic degradation of the
endothelial glycocalyx [5]. These data indicate the impor-
tance of measuring coronary blood volume in addition to
ﬂow in humans that are at risk for glycocalyx degradation,
i.e., patients with diabetes or hypercholesterolemia [23,
28]. However, coronary blood volume measurements are
currently not routinely applied in the clinic. Dye or
radioactive labeling techniques and extensive catheteriza-
tion cannot be used in humans or performed repeatedly to
assess dynamic changes. Nevertheless, myocardial blood
volume can be measured non-invasively in humans using
myocardial contrast echocardiography [14]; MRI and
electron-beam CT have this potential as well. The latter
two techniques have already been used in combination with
indicator dilution for measurement of myocardial perfusion
[2, 15, 19, 34, 35], and to do so, a ﬁt through the indicator
concentration data is required, similar as for the volume
measurement. Therefore, the comparison of the different
models for ﬁtting the indicator concentration data, as done
in this study, is useful for the measurement of both coro-
nary blood volume as well as perfusion.
In conclusion, when determining coronary blood or
plasma volume using the indicator-dilution technique, the
gamma-variate and LDRW model appear to be good
alternatives to the mono-exponential model, with the
advantage that these models take both ascending and
descending slope of the curve into account (and therefore
less data of descending slope is required), and are less
sensitive to noise. A shortcoming of these models, how-
ever, appears to be that they tend to underestimate the tail
of the indicator-dilution curve more than the mono-expo-
nential and power-law model.
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